These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23705996)

  • 41. Subretinal Transplantation of Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration: An Assessment at 4 Years.
    Schwartz SD; Tan G; Hosseini H; Nagiel A
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(5):ORSFc1-9. PubMed ID: 27116660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cells: a new paradigm for disease modeling and developing therapies for age-related macular degeneration.
    Melville H; Carpiniello M; Hollis K; Staffaroni A; Golestaneh N
    J Transl Med; 2013 Mar; 11():53. PubMed ID: 23452406
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retinal Cell Transplantation, Biomaterials, and In Vitro Models for Developing Next-generation Therapies of Age-related Macular Degeneration.
    Rizzolo LJ; Nasonkin IO; Adelman RA
    Stem Cells Transl Med; 2022 Mar; 11(3):269-281. PubMed ID: 35356975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer "cell therapy" clinics.
    Hinkle JW; Mahmoudzadeh R; Kuriyan AE
    Stem Cell Res Ther; 2021 Oct; 12(1):538. PubMed ID: 34635174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human pluripotent stem cell strategies for age-related macular degeneration.
    Davidson KC; Guymer RH; Pera MF; Pébay A
    Optom Vis Sci; 2014 Aug; 91(8):887-93. PubMed ID: 24859130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effective mobilisation of bone marrow-derived cells through proteolytic activity: a new treatment strategy for age-related macular degeneration.
    Li H; Yan Z; Cao H; Wang Y
    Med Hypotheses; 2012 Feb; 78(2):286-90. PubMed ID: 22129485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human iPSC-Derived Neural Progenitors Preserve Vision in an AMD-Like Model.
    Tsai Y; Lu B; Bakondi B; Girman S; Sahabian A; Sareen D; Svendsen CN; Wang S
    Stem Cells; 2015 Aug; 33(8):2537-49. PubMed ID: 25869002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Embryonic Stem Cells to Treat Severe Eye Diseases.
    Aznar J; Tudela J
    Cuad Bioet; 2016; 27(90):241-7. PubMed ID: 27637197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First evidence of long term safety of human embryonic stem cells is reported.
    Wise J
    BMJ; 2014 Oct; 349():g6248. PubMed ID: 25318639
    [No Abstract]   [Full Text] [Related]  

  • 50. Surgical Transplantation of Human RPE Stem Cell-Derived RPE Monolayers into Non-Human Primates with Immunosuppression.
    Liu Z; Parikh BH; Tan QSW; Wong DSL; Ong KH; Yu W; Seah I; Holder GE; Hunziker W; Tan GSW; Barathi VA; Lingam G; Stanzel BV; Blenkinsop TA; Su X
    Stem Cell Reports; 2021 Feb; 16(2):237-251. PubMed ID: 33450191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cell-Based Therapy for Degenerative Retinal Disease.
    Zarbin M
    Trends Mol Med; 2016 Feb; 22(2):115-134. PubMed ID: 26791247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
    Rasmussen H; Chu KW; Campochiaro P; Gehlbach PL; Haller JA; Handa JT; Nguyen QD; Sung JU
    Hum Gene Ther; 2001 Nov; 12(16):2029-32. PubMed ID: 11727737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Retinal regeneration with iPS cells ‒ Clinical trials for retinal degenerative disorders].
    Sugita S
    Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):79-85. PubMed ID: 26016634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulatory role of HIF-1alpha in the pathogenesis of age-related macular degeneration (AMD).
    Arjamaa O; Nikinmaa M; Salminen A; Kaarniranta K
    Ageing Res Rev; 2009 Oct; 8(4):349-58. PubMed ID: 19589398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration.
    Mettu PS; Wielgus AR; Ong SS; Cousins SW
    Mol Aspects Med; 2012 Aug; 33(4):376-98. PubMed ID: 22575354
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD).
    Pulido J; Sanders D; Winters JL; Klingel R
    J Clin Apher; 2005 Oct; 20(3):185-94. PubMed ID: 15892078
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stem cells in clinical trials for treatment of retinal degeneration.
    Klassen H
    Expert Opin Biol Ther; 2016; 16(1):7-14. PubMed ID: 26414165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [RPE transplantation: the challenges and the future].
    Boulton ME
    Ophthalmologe; 2004 Sep; 101(9):877-81. PubMed ID: 15448991
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats.
    Schraermeyer U; Thumann G; Luther T; Kociok N; Armhold S; Kruttwig K; Andressen C; Addicks K; Bartz-Schmidt KU
    Cell Transplant; 2001; 10(8):673-80. PubMed ID: 11814109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Adult human retinal pigment epithelial cells - a potential source of cells for regeneration retina].
    Kuznetsova AV; Grirorian ÉN; Aleksandrova MA
    Tsitologiia; 2011; 53(6):505-12. PubMed ID: 21870507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.